Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter, averaging 19.4 per cent, as per a report by brokerage firm Motilal Oswal.
Nifty earnings are expected to witness a modest growth of 5 per cent in FY25, marking the first year of single-digit growth in the past five years, according to a report by Motilal Oswal.
The Indian IT sector is poised for strong earnings growth in the coming years, with a projected double-digit Earnings Per Share (EPS) Compound Annual Growth Rate (CAGR) of 17.5 per cent from FY24 to FY27, according to a recent industry analysis report by Nirmal Bang Equities.
The financial services company said it sees continued strength in refining business, a likely rebound in petrochemicals (petrochem) spreads from decadal low levels from China re-opening, and volume growth in exploration and production (E and P) - driving earnings growth.
New Delhi [India], December 29 (ANI): Improved asset quality and consequently lower credit provisions can drive better profitability for banks and provide impetus to lenders and rejuvenate their lending decisions, ICRA Ratings has said.